Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 51NIH 2NETWORK 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 1Classical hematology 1

Conditions

Lymphoma 13Neuroblastoma 10Leukemia 9Central Nervous System Neoplasms 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Brain Neoplasms 8Hodgkin Disease 5Burkitt Lymphoma 5Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large B-Cell, Diffuse 4Dendritic Cell Sarcoma, Interdigitating 4Medulloblastoma 3Leukemia, Biphenotypic, Acute 3Astrocytoma 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Osteosarcoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Malignant mesenchymal tumor 2Leukemia, Myeloid, Acute 2Leukemia, Monocytic, Acute 2Kidney Neoplasms 2Cardiotoxicity 2Carcinoma, Renal Cell 2

Interventions

Cytarabine 7Busulfan 7Cyclophosphamide 6Whole-Body Irradiation 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5fludarabine 4Methotrexate 4fludarabine phosphate 3Tacrolimus 3Radiotherapy 3Melphalan 3Daunorubicin 3Cyclosporine 3Asparaginase 3merphos 2Thioguanine 2Patient Reported Outcome Measures 2Mitoxantrone 2Mesna 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Gemtuzumab 2Filgrastim 2Bone Marrow Transplantation 2Azacitidine 2Antilymphocyte Serum 2zosuquidar trihydrochloride 1treosulfan 1thymoglobulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Myelodysplastic Syndromes × Granulocyte Colony-Stimulating Factor × Clear all
NCT02793544 2025-08-06

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Center for International Blood and Marrow Transplant Research

Phase 2 Completed
80 enrolled 56 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00046930 2023-07-05

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

Eastern Cooperative Oncology Group

Phase 3 Completed
449 enrolled 9 charts
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡